产品封面图

Recombinant Dengue protein (co

ntains 13 immuno-reactive epitpes)
收藏
  • ¥1980
  • 博尔森生物
  • BES2P41421
  • 中国/上海
  • 2025年10月29日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 供应商

      上海博尔森生物科技有限公司

    • 库存

      大量

    • 英文名

      Recombinant Dengue protein (contains 13 immuno-reactive epitpes)

    • 保质期

      12个月

    • 保存条件

      Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles.

    • 规格

      100ul

    重组登革热多表位抗原
    Recombinant Dengue protein(contains 13 immuno-reactive epitpes)
    Cat. Number: BES2P41421
    Product name: Recombinant Dengue protein
    (contains 13 immuno-reactive epitpes)
    Expression system: E.coli
    Tags: Tag free
    Detected MW: 16 kDa
    Format: Liquid
    Purity: >95% as determined by SDS-PAGE
    Concentration: >0.5 mg/ml
    Buffer: PBS (pH=7.4)
    产品细节图片1
    Storage: Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles.
    Important Note: This product as supplied is intended for research use only, not for use in human,therapeutic or diagnostic applications. Description: This protein is a dengue protein for dengue antibody rapid test. This protein contains 13 immuno-reactive epitpes derived from
    dengue genome,it reacts to most four serotype dengue antibodies.The rapid test prepared by this protein has over 90% sensitivity and specifity over 95% to detect both dengue IgM and IgG.
    特别提示:本公司的所有产品仅可用于科研实验,严禁用于临床医疗及其他非科研用途!以实际收货产品说明书为准,网站说明书仅供参考。

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • Detection of Dengue Virus

      against dengue, timely diagnosis is therefore necessary for patient management. Laboratory diagnosis is carried out by virus isolation, demonstration of viral antigen, presence of viral nucleic acid, and antibodies. Further, recombinant dengue envelope protein

    • Isolation of Recombinant MVA Using F13L Selection

      Modified vaccinia virus Ankara (MVA) has become a widely used vector for vaccine and laboratory purposes. Despite significant advances in recombinant MVA technology, the isolation of recombinant viruses remains a tedious and difficult process

    • Recombinant Protein Production in Yeasts

      Recombinant protein production is a multibillion-dollar market. The development of a new product begins with the choice of a production host. While one single perfect host for every protein does not exist, several expression systems ranging

    图标技术资料

    需要更多技术资料 索取更多技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥2980
    上海博尔森生物科技有限公司
    2025年10月29日询价
    询价
    北京博蕾德生物科技有限公司
    2025年06月22日询价
    询价
    上海瑶韵生物科技有限公司
    2025年07月15日询价
    ¥500
    北京百奥创新科技有限公司
    2025年06月18日询价
    Recombinant Dengue protein (contains 13 immuno-reactive epitpes)
    ¥1980